Dr. Parveen Azam is a Chicago, Illinois based psychiatrist who is specialized in Addiction Medicine. Her current practice location is 820 S Damen Ave, Chicago. Patients can reach her at 312-569-6951. Dr. Parveen Azam is M.D. in Addiction Medicine and her NPI number (Unique professional ID assigned by NPPES) is 1477639078.
Dr. Parveen Azam focuses on the evaluation, diagnosis, and treatment of people who have one or more disorders related to addictions like illegal drugs, alcohol, and prescription medication and other substances.
Complete Profile:
Dr. Parveen Azam speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
| Name: | Dr. Parveen Azam |
| Specialization: | Addiction Medicine |
| Gender: | Female |
| Credentials: | M.D. |
| Practice Address: | 820 S Damen Ave, Chicago,
Illinois, 60612-3728 |
| Phone: | 312-569-6951 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
| NPI Number: | 1477639078 |
| NPI Enumeration Date: | 27 Oct, 2006 |
| NPI Last Update On: | 08 Jul, 2007 |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | Dr. Parveen Azam
435 William St Unit 607,
River Forest, Illinois |
| Zip: | 60305-1989 |
| Phone Number: | 708-366-4996 |
Patients can reach Dr. Parveen Azam at
820 S Damen Ave, Chicago, Illinois or can
call to book an appointment on 312-569-6951.
Comments/ Reviews:
Read all the reviews posted for Dr. Parveen Azam below. You may also share your own experience with Dr. Parveen Azam. Your feedback can help others make better decisions.
**
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.